HK Stock Market Move | Meituan-W (03690) rose more than 4% in the afternoon, Keeta officially launched operations in Kuwait, and the internationalization process significantly accelerated.
Meituan-W (03690) rose more than 4% in the afternoon, up 3.54% as of the latest update, to HK$100.8, with a turnover of HK$6.553 billion.
MEITUAN-W (03690) rose more than 4% in the afternoon, with an increase of 3.54% as of press time, trading at 100.8 Hong Kong dollars with a turnover of 6.553 billion Hong Kong dollars.
On the news front, on September 15th, Meituan's international food delivery brand Keeta officially launched its operations in Kuwait, becoming its third landing point in the Middle East Gulf region after Saudi Arabia and Qatar. It is reported that since entering Saudi Arabia in September 2024, Keeta's user base and order volume have grown rapidly. In August of this year, Keeta launched in Qatar, and less than a month later, it officially entered Kuwait. In the future, Keeta will continue to deepen its presence in the Middle East and actively explore more new overseas markets.
It is worth noting that, according to the Science and Technology Innovation Board Daily, reporters have learned that Meituan's first AI Agent product "Xiaomei" App will be testing publicly. "Xiaomei" is positioned as a "small and beautiful AI life assistant" and is equipped with the self-developed LongCat-Flash-Chat model released at the beginning of the month by Meituan. Through simple natural language interaction and internal interface calling, it can provide experiences such as food delivery ordering, restaurant recommendations, and reservation navigation for local living services.
Related Articles

WEIHAI BANK (09677) has fully redeemed 3 billion yuan of subordinated capital bonds.

Beijing Foyou Pharma (601089.SH): Pioglitazone Metformin Tablets (15mg/850mg) Obtains Drug Registration Certificate.

ZHAOBANGJI LIFE (01660) intends to change its name to "Qiyuan Investment Holdings Limited".
WEIHAI BANK (09677) has fully redeemed 3 billion yuan of subordinated capital bonds.

Beijing Foyou Pharma (601089.SH): Pioglitazone Metformin Tablets (15mg/850mg) Obtains Drug Registration Certificate.

ZHAOBANGJI LIFE (01660) intends to change its name to "Qiyuan Investment Holdings Limited".
